查看购物车
  • Traditional Chinese
  • English
中东和非洲肌肉减少症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型和配销通路
市场调查报告书
商品编码
1562370

中东和非洲肌肉减少症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型和配销通路

Middle East & Africa Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 70 Pages | 订单完成后即时交付

价格

2022年中东和非洲肌肉减少症治疗市场价值为6,659万美元，预计到2030年将达到9,055万美元；预计2022年至2030年复合年增长率为3.9%。

人们对肌少症的认识不断提高，促进了中东和非洲肌少症治疗市场

人们对肌少症及其对健康的负面影响的认识不断提高，为医疗保健和老年护理领域的进步提供了广阔的空间。许多倡议团体和组织正在积极采取措施，提高群众对肌少症的认识。这些组织经常与医疗专业人员合作，让大众了解某些疾病的各个方面的最新情况，例如致病性、目标患者、预防和治疗，并强调及时诊断和治疗的价值。根据 OWH 的「强于肌少症」运动，敦促女性与医疗保健提供者讨论肌少症，然后接受疾病筛检，并在需要时采取适当的治疗。

肌少症已被纳入医学院的课程和针对医生、护士和物理治疗师等医疗保健专业人员的培训计划。例如，OWH 与 Medscape Education 合作，为医疗保健专业人员创建继续医学教育 (CME) 学分，这将使他们能够更好地检测和治疗患者的肌肉减少症。主流媒体已扩大对肌少症的报导，包括文章、新闻报导和纪录片。因此，人们对肌少症认识的提高可能会在未来几年为肌少症治疗市场带来新的成长趋势。

中东和非洲肌少症治疗市场概述

中东和非洲肌少症治疗市场分为沙乌地阿拉伯、阿联酋、南非和中东和非洲其他地区。由于骨科疾病发生率不断上升，阿联酋和沙乌地阿拉伯是市场最重要的贡献者之一。提高广大人口对营养补充剂的使用和益处的认识也有利于市场的进步。

南非肌少症风险的增加与人口老化以及贫穷导致的粮食安全和营养摄取不足有关。预计该国的肌少症治疗市场将受到卫生当局为诊断、治疗和预防肌少症而采取的独特的针对特定人群的方法的推动。

中东及非洲肌肉减少症治疗市场收入及 2030 年预测（百万美元）

中东和非洲肌少症治疗市场区隔

中东和非洲肌少症治疗市场按治疗类型、配销通路和国家分类。

根据治疗类型，中东和非洲肌少症治疗市场分为维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等。 2022 年，维生素 D 和钙补充剂领域占据中东和非洲肌肉减少症治疗市场最大份额。

在配销通路方面，中东和非洲肌少症治疗市场分为药局、零售通路、线上通路等。 2022 年，药局细分市场占据中东和非洲肌肉减少症治疗市场最大份额。

按国家/地区划分，中东和非洲肌少症治疗市场分为沙乌地阿拉伯、南非、阿联酋以及中东和非洲其他地区。 2022 年，南非在中东和非洲肌肉减少症治疗市场份额中占据主导地位。

雅培实验室、拜耳公司、雀巢健康科学公司、诺华公司、辉瑞公司、赛诺菲公司、安丽公司和葛兰素史克公司是中东和非洲肌少症治疗市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：中东和非洲肌肉减少症治疗市场 - 主要产业动态

  • 中东和非洲肌少症治疗市场 - 主要产业动态
  • 市场驱动因素
    • 老年人口激增
    • 成人营养不良和维生素缺乏症增加
  • 主要市场限制：
    • 无法直接干预
  • 主要市场机会：
    • 处于临床试验阶段的产品
  • 未来趋势：
    • 人们对肌少症的认识不断提高
  • 驱动因素和限制的影响：

第 5 章：肌少症治疗市场 - 中东和非洲市场分析

  • 中东和非洲肌少症治疗市场收入，2020 - 2030
  • 中东与非洲肌少症治疗市场预测与分析

第 6 章：中东和非洲肌肉减少症治疗市场分析 - 按治疗类型

  • 维生素 D 和钙补充剂
  • 蛋白质补充剂
  • 维生素 B12 补充剂
  • 其他的

第 7 章：中东和非洲肌肉减少症治疗市场分析 - 按配销通路

  • 药局
  • 零售通路
  • 线上通路
  • 其他的

第 8 章：中东和非洲肌肉减少症治疗市场 - 国家分析

  • 中东和非洲
    • 南
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区

第 9 章：肌少症治疗市场-产业格局

  • 概述
  • 肌少症治疗市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 10 章：公司简介

  • Abbott Laboratories
  • Bayer AG
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc

第 11 章：附录

Product Code: BMIRE00030473

The Middle East & Africa sarcopenia treatment market was valued at US$ 66.59 million in 2022 and is expected to reach US$ 90.55 million by 2030; it is estimated to register a CAGR of 3.9% from 2022 to 2030.

Rising Awareness About Sarcopenia Bolster Middle East & Africa Sarcopenia Treatment Market

The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of certain disorders, such as pathogenicity, target patients, prevention, and treatments, along with underlining the value of prompt diagnosis and treatment. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.

Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.

Middle East & Africa Sarcopenia Treatment Market Overview

The Middle East & Africa sarcopenic treatment market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The UAE and Saudi Arabia are among the most significant contributors to the market due to the rising incidence of orthopedic disorders. Increasing awareness among the large population about the use and benefits of nutritional supplements also benefits the market progress.

An increased risk of sarcopenia in South Africa is associated with the aging population, and inadequate food security and nutrient intake brought on by poverty. The sarcopenia treatment market in this country is anticipated to be driven by a distinct population-specific approach taken by health authorities for the diagnosis, treatment, and prevention of sarcopenia.

Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Sarcopenia Treatment Market Segmentation

The Middle East & Africa sarcopenia treatment market is categorized into treatment type, distribution channel, and country.

Based on treatment type, the Middle East & Africa sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Middle East & Africa sarcopenia treatment market share in 2022.

In terms of distribution channel, the Middle East & Africa sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Middle East & Africa sarcopenia treatment market share in 2022.

By country, the Middle East & Africa sarcopenia treatment market is segmented into Saudia Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa sarcopenia treatment market share in 2022.

Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the Middle East & Africa sarcopenia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics

  • 4.1 Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Upsurge in Geriatric Population
    • 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 4.3 Key Market Restraints:
    • 4.3.1 Unavailability of Direct Interventions
  • 4.4 Key Market Opportunities:
    • 4.4.1 Products in Clinical Trial Phases
  • 4.5 Future Trends:
    • 4.5.1 Rising Awareness About Sarcopenia
  • 4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Middle East & Africa Market Analysis

  • 5.1 Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • 5.2 Middle East & Africa Sarcopenia Treatment Market Forecast and Analysis

6. Middle East & Africa Sarcopenia Treatment Market Analysis - By Treatment Type

  • 6.1 Vitamin D and Calcium Supplement
    • 6.1.1 Overview
    • 6.1.2 Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Protein Supplement
    • 6.2.1 Overview
    • 6.2.2 Protein Supplement : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Vitamin B12 Supplement
    • 6.3.1 Overview
    • 6.3.2 Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 7.1 Pharmacies
    • 7.1.1 Overview
    • 7.1.2 Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Retail Channels
    • 7.2.1 Overview
    • 7.2.2 Retail Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Online Channels
    • 7.3.1 Overview
    • 7.3.2 Online Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Sarcopenia Treatment Market - Country Analysis

  • 8.1 Middle East & Africa
    • 8.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.5 Rest of Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.5.1 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.5.2 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Sarcopenia Treatment Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Bayer AG
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Nestle Health Science SA
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Novartis AG
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Pfizer Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Sanofi SA
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Amway Corp
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 GSK Plc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Middle East & Africa Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Country
  • Table 7. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 8. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 9. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 10. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 11. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 12. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 13. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 14. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 15. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 16. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 17. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Middle East & Africa Sarcopenia Treatment Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 5. Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Protein Supplement : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 10. Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Retail Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Online Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Middle East & Africa Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
  • Figure 15. Middle East & Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 16. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
  • Figure 17. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
  • Figure 18. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 19. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 20. Growth Strategies in the Sarcopenia Treatment Market